author-photo

G J S Rustin

Charing Cross Hospital

127

Papers

6736

Citations

Citation Trend

Filter By

Papers (97) Sort By

Journal Conference Others

714P Prognostic factors in stage I seminoma: Data from the phase III, randomised TRial of Imaging and Surveillance in Seminoma Testis (TRISST)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

2021
Show All
- Source
- Cite
- Save
Citations (1)
794P UK practices for treatment of relapse in seminoma testicular cancer

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase II study of decitabine in combination with carboplatin compared with carboplatin alone in patients with recurrent advanced ovarian cancer

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)
Randomized trial of intrapatient dose escalation of single agent carboplatin as first-line treatment for advanced ovarian cancer: An SGCTG study (SCOTROC 4)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Maintenance erlotinib (E) following first-line treatment with docetaxel, carboplatin and erlotinib in patients with ovarian carcinoma

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
EMA/CO for High-Risk Gestational Trophoblastic Tumors

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy

2016 Cancer
Show All
- Source
- Cite
- Save
Citations (31)
Erhaltungstherapie mit Olaparib nach platinhaltiger Re-induktion bei platinsensitivem serösem Ovarialkarzinomrezidiv: eine Placebo-kontrollierte Phase II Studie

2014 Geburtshilfe Und Frauenheilkunde
Show All
- Source
- Cite
- Save
Citations (2)
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

2014 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (83)